Correlation between Length-to-width Ratio of Gallbladder and Gamma-glutamyl Transferase Value in Biliary Atresia

Ryan Elmanar, Lenny Violetta, Rosy Setiawati

Abstract


Biliary atresia represents one of the most prevalent etiologies for neonatal cholestasis. Unmanaged biliary atresia can be fatal. Ultrasonography is the primary diagnostic test because it's accurate, cost-effective, and available. Various ultrasound findings can assist in diagnosing biliary atresia; the length-to-width ratio of the gallbladder is a particularly advantageous method, offering a short examination time, objectivity, and ease of use, with an accuracy rate of 78.9%. In cases with unconventional ultrasound findings, gamma-glutamyl transferase is believed to be able to complete the diagnostic process with an accuracy rate of up to 80%. The optimal cut-off value differs between studies, making it challenging to use as a benchmark for biliary atresia detection. In this study, researchers aim to further investigate the relationship between length-to-width ratio and gamma-glutamyl transferase in cases of biliary atresia, compared to the liver biopsy results in these patients and the optimal cut-off. This study employed an observational analytic approach with a retrospective design. The sample population consisted of all patients with neonatal cholestasis who underwent laboratory and ultrasonographic examinations at Dr. Soetomo Academic General Hospital Surabaya between 2019 and 2023. The study population comprised 82 patients. A significant relationship (p-value<0.001) was observed between the length-to-width ratio of the gallbladder and biliary atresia, as well as between gamma-glutamyl transferase and biliary atresia (area under the curve: 0.7–0.8). However, the analysis between the length-to-width ratio of the gallbladder and the value of gamma-glutamyl transferase showed p-value=0.066, which means no significant relationship was observed between the length-to-width ratio and gamma-glutamyl transferase.

Keywords


Biliary atresia; gamma-glutamyl transferase; length-to-width ratio; ultrasound

Full Text:

PDF

References


Schreiber RA, Barker CC, Roberts EA, Martin SR, Alvarez F, Smith L, et al. Biliary atresia: the Canadian experience. J Pediatr. 2007;151(6):659–65, 665.e1.

Adam A, Dixon AK, Gillard JH, Schaefer-Prokop CM, editors. Grainger & Allison’s diagnostic radiology a textbook of medical imaging. 7th Edition. Warsaw, Poland: Elsevier Ltd.; 2021.

Setyoboedi B, Utomo MT, Prihaningtyas RA, Winahyu AK, Arief S. Tingkat pengetahuan atresia bilier pada bidan di puskesmas Kabupaten Sidoarjo. J Abdi Insani. 2022;9(4):1839–46.

arollo V, Gentile G, Di Piazza A, Marrone G, Milazzo M, Mamone G, et al. The role of ultrasound in the early diagnosis of biliary atresia [Internet]. Vienna, Austria: European Society of Radiology; 2018 [cited 2024 August 10]. Available from: https://dx.doi.org/10.1594/ecr2018/C-1472.

Napolitano M, Franchi-Abella S, Damasio MB, Augdal TA, Avni FE, Bruno C, et al. Practical approach to imaging diagnosis of biliary atresia, Part 1: prenatal ultrasound and magnetic resonance imaging, and postnatal ultrasound. Pediatr Radiol. 2021;51(2):314–31.

Wang G, Zhang N, Zhang X, Zhou W, Xie X, Zhou L. Ultrasound characteristics combined with gamma-glutamyl transpeptidase for diagnosis of biliary atresia in infants less than 30 days. Pediatr Surg Int. 2021;37(9):1175–82.

Sulistio PA, Violetta L, Rahniayu A. Diagnostic value of ultrasound parameter in neonatal biliary atresia based on histopathological results (ultrasound study of triangular cord sign and gallbladder abnormality). Int J Res Publ. 2022;108(1):316–22.

Zhang K, Tang Y, Zheng Z, Tang C, Zhu D, Du Q, et al. Value of gallbladder length-to-width ratio for diagnosis of biliary atresia by correlation with age. Updates Surg. 2023;75(4):915–20.

Sun Y, Dai S, Shen Z, Yang Y, Hong S, Dong R, et al. Gamma-glutamyl transpeptidase has different efficacy on biliary atresia diagnosis in different hospital patient groups: an application of machine learning approach. Pediatr Surg Int. 2022;38(8):1131–41.

Sira MM, Salem TAH, Sira AM. Biliary atresia: a challenging diagnosis. Glob J Gastroenterol Hepatol. 2013;1(1):24–35.

Zhou W, Zhou L. Ultrasound for the diagnosis of biliary atresia: from conventional ultrasound to artificial intelligence. MDPI. 2022;

Silveira TR, Salzano FM, Donaldson PT, Mieli-Vergani G, Howard ER, Mowat AP. Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr. 1993;16(2):114–7.

Black AJ, Lu DY, Yefet LS, Baird R. Sex differences in surgically correctable congenital anomalies: a systematic review. J Pediatr Surg. 2020;55(5):811–20.

Nio M, editor. Introduction to biliary atresia. Berlin: Springer Nature; 2021.

Choochuen P, Kritsaneepaiboon S, Charoonratana V, Sangkhathat S. Is “gallbladder length-to-width ratio” useful in diagnosing biliary atresia? J Pediatr Surg. 2019;54(9):1946–52.

Tang KS, Huang LT, Huang YH, Lai CY, Wu CH, Wang SM, et al. Gamma-glutamyl transferase in the diagnosis of biliary atresia. Acta Paediatr Taiwanica. 2007;48(4):196–200.

Kotb MA. Review of historical cohort: ursodeoxycholic acid in extrahepatic biliary atresia. J Pediatr Surg. 2008;43(7):1321–7.

Robles-Diaz M, Garcia-Cortes M, Medina-Caliz I, Gonzalez-Jimenez A, Gonzalez-Grande R, Navarro JM, et al. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity. Liver Int. 2015;35(11):2474–82.

Simental-Mendía M, Sánchez-García A, Simental-Mendía LE. Effect of ursodeoxycholic acid on liver markers: a systematic review and meta-analysis of randomized placebo-controlled clinical trials. Br J Clin Pharmacol. 2020;86(8):1476–88.

Weng Z, Zhou W, Wu Q, Ma H, Fang Y, Dang T, et al. Gamma-glutamyl transferase combined with conventional ultrasound features in diagnosing biliary atresia: a two-center retrospective analysis. J Ultrasound Med. 2022;41(11):2805–17.

Kong F, Dong R, Chen G, Sun S, Yang Y, Jiang J, et al. Progress in biomarkers related to biliary atresia. J Clin Transl Hepatol. 2024;12(3):305–15.




DOI: https://doi.org/10.29313/gmhc.v12i3.14170

pISSN 2301-9123 | eISSN 2460-5441


Visitor since 19 October 2016: 


Free counters!


Global Medical and Health Communication is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.